News | August 07, 2021
Bafna Pharma posts Q1FY 21-22 net at Rs. 2.08 Cr
This robust growth has come despite the raging pandemic for most part of the quarter
This robust growth has come despite the raging pandemic for most part of the quarter
The proposed acquisition will further bolster Strides US presence through acquisition of a multi dosage facility in the US.
It had an estimated market size of US $ 32 million as of June 2021
MitraClip implants give a new lease of life for frail and elderly patients who cannot go in for conventional open-heart surgery
Deal for 100 million doses with additional 100 million through 2023
Arrow is the marketing partner in US
It is part of the company’s pain/analgesics portfolio of OTC products
Ultreon 1.0 Software, the first-of-its-kind imaging software, merges optical coherence tomography with the power of automation using AI -
Aditya Puri former MD of HDFC bank joins Solara board as chairman
Subscribe To Our Newsletter & Stay Updated
